Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Direxion Auspice Broad Commodity Strategy ETF COM

The investment seeks to provide total return that exceeds that of the Auspice Broad Commodity Index over a complete market cycle. The fund is an actively managed ETF that seeks to provide total return that exceeds that of the index. It will generally seek to maintain a portfolio of instruments similar to those included in the index by utilizing exchange-traded commodity futures contracts and... see more

Recent & Breaking News (ARCA:COM)

    Direxion's Relative Weight ETFs Now Available Commission-Free at Schwab

    PR Newswire July 9, 2019

    Cardiome Provides U.S. Regulatory Update For BRINAVESS

    Canada NewsWire August 21, 2017

    Cardiome Reports Second Quarter 2017 Financial Results

    Canada NewsWire August 8, 2017

    Cardiome To Hold Second Quarter 2017 Financial Results Conference Call On August 8

    Canada NewsWire August 1, 2017

    Cardiome Announces Health Canada Approval of AGGRASTAT® High Dose Bolus Regimen

    Canada NewsWire July 17, 2017

    Cardiome's Partner SteadyMed Submits U.S. New Drug Application for TREVYENT® for the Treatment of Pulmonary Arterial Hypertension

    Canada NewsWire July 3, 2017

    Cardiome Pharma Corp. Announces Voting Results

    Canada NewsWire June 23, 2017

    Cardiome Announces Licensing Agreement for XYDALBA™ (Dalbavancin Hydrochloride) to Support Planned Commercialization in Israel

    Canada NewsWire June 21, 2017

    Cardiome Announces Commercial Launch of BRINAVESS® (Vernakalant Hydrochloride) in Canada

    Canada NewsWire June 12, 2017

    Cardiome Reports Changes To Senior Management Team

    PR Newswire May 16, 2017

    Cardiome Reports First Quarter 2017 Financial Results

    PR Newswire May 15, 2017

    Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds

    Canada NewsWire May 15, 2017